We are live on ! Find out more
NUTX icon

Nutex Health

49 hedge funds and large institutions have $6.39M invested in Nutex Health in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

14% more capital inflows, than outflows

Capital inflows: $1.34M | Capital outflows: $1.17M

0.04% more ownership

Funds ownership: 5.3% → 5.34% (+0.04%)

17% less funds holding

Funds holding: 59 → 49 (-10)

50% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 20

Holders
49
Holders Change
-10
Holders Change %
-16.95%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
12
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NUTX Hedge Fund Activity: Q4 2023 in Review

49 of the 6,877 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q4 2023, worth a combined $6.39M — down 10% from $7.1M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of NUTX and 10 opened new positions — a net loss of 10 holders — while 12 trimmed existing stakes and 15 added.

The largest buyer was Truist Financial, adding an estimated $420K. The largest seller was Bank of America, cutting an estimated $343K.

  • 49 institutional investors held Nutex Health (NUTX) as of Q4 2023, down from 59 in Q3 2023.
  • Funds reported $6.39M of Nutex Health stock for Q4 2023, down 10% quarter-over-quarter.
  • 10 funds opened new Nutex Health positions in Q4 2023 and 20 closed out, a net change of -10 holders.
  • The largest Nutex Health buyer in Q4 2023 was Truist Financial, an estimated $420K added.
  • The largest Nutex Health seller in Q4 2023 was Bank of America, an estimated $343K sold.

Based on aggregated 13F filings for Q4 2023.